SOMA: SCREENING AND SOMATIC HEALTH INTERVENTION PROGRAM FOR PEOPLE WITH SEVERE MENTAL ILLNESS.

Progress in psychiatric treatment has led to important improvements in the quality of life of patients with severe mental illness (SMI). Nevertheless, the life expectancy of patients with SMI remains two decades shorter than that of the general population, and the most prevalent cause of death is cardiovascular disease. Given that the delivery of somatic care to a population of individuals with mental illness is specific, we developed a screening and intervention programme aimed at this vulnerable population.

Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health.

A large proportion of the world's disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring, are also routinely recognised.

Complication during hospitalization of geronto-psychiatric patient for fatal Stevens-Johnson syndrome - a multidisciplinary approach.

In the department of gerontopsychiatry we can encounter various conditions that complicate basic psychiatric treatment, often because of old age, polymorbidity and fragility of hospitalized patients. Stevens-Johnson Syndrome (SJS) is a rare disease with high mortality. The case report describes the course of the patient's disease, including treatment, interventions and pharmacological considerations with an emphasis on multidisciplinary cooperation.